VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Post by GoTogetheron Dec 20, 2017 5:15pm

190 Views

Post# 27199758

Obtaining CE mark - timelines

" ... Given the straightforward classification process and the focus on safety and performance, a CE mark can be usually obtained in a relatively short time. If the company has a quality system in place in line with ISO 13485 and the Technical File is complete, the timeline can range from two to three - four months after quality audit and file submission. ... "

[url=https://]https://www.medical-risk.com/project-management/ce-marking[/url]

EOM.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario